Older Patients With Newly Diagnosed Breast Cancer or Colon Cancer
| Status: | Terminated |
|---|---|
| Conditions: | Breast Cancer, Colorectal Cancer, Cancer, Cognitive Studies, Psychiatric |
| Therapuetic Areas: | Oncology, Psychiatry / Psychology |
| Healthy: | No |
| Age Range: | 65 - Any |
| Updated: | 4/21/2016 |
| Start Date: | March 2008 |
| End Date: | September 2011 |
The Vulnerable Elders Survey Study of Older Cancer Patients
RATIONALE: Learning about changes over time in older patients' ability to function after
receiving chemotherapy for breast or colon cancer may help doctors learn about the long-term
effects of treatment and plan the best treatment.
PURPOSE: This clinical trial is studying older patients with newly diagnosed breast cancer
or colon cancer.
receiving chemotherapy for breast or colon cancer may help doctors learn about the long-term
effects of treatment and plan the best treatment.
PURPOSE: This clinical trial is studying older patients with newly diagnosed breast cancer
or colon cancer.
OBJECTIVES:
- Determine the correlation between the Vulnerable Elders Survey (VES-13) and the battery
of Comprehensive Geriatric Assessment tools among breast and colon cancer patients, 65
years and older, in an outpatient setting.
- Assess and compare the abilities of the VES-13 and the battery of Comprehensive
Geriatric Assessment tools to predict chemotherapy adherence among these patients.
- Examine the validity of the VES-13 screening tool to identify increased risk of death
from all causes at one year after initial VES-13 screening in these patients.
- Examine the validity of the VES-13 screening tool to identify increased risk of
functional decline at one year after initial VES-13 screening in these patients.
OUTLINE: Patients complete the Vulnerable Elders Survey (VES-13) and a Comprehensive
Geriatric Assessment at baseline and 12 months later. Variables collected include
sociodemographics; cognitive, nutritional, psychosocial, and emotional status; tumor
characteristics; therapy; and mortality.
Patients are followed for 1 year for chemotherapy adherence and survival.
- Determine the correlation between the Vulnerable Elders Survey (VES-13) and the battery
of Comprehensive Geriatric Assessment tools among breast and colon cancer patients, 65
years and older, in an outpatient setting.
- Assess and compare the abilities of the VES-13 and the battery of Comprehensive
Geriatric Assessment tools to predict chemotherapy adherence among these patients.
- Examine the validity of the VES-13 screening tool to identify increased risk of death
from all causes at one year after initial VES-13 screening in these patients.
- Examine the validity of the VES-13 screening tool to identify increased risk of
functional decline at one year after initial VES-13 screening in these patients.
OUTLINE: Patients complete the Vulnerable Elders Survey (VES-13) and a Comprehensive
Geriatric Assessment at baseline and 12 months later. Variables collected include
sociodemographics; cognitive, nutritional, psychosocial, and emotional status; tumor
characteristics; therapy; and mortality.
Patients are followed for 1 year for chemotherapy adherence and survival.
DISEASE CHARACTERISTICS:
- Histologically confirmed breast or colon cancer
- Newly diagnosed disease
- Any stage disease
- Undergoing treatment at the Ireland Cancer Center, University Hospitals Case Medical
Center Site
- Scheduled to start a new chemotherapy regimen (objective II only)
- Not concurrently enrolled in a GEM trial (objectives II, III, and IV)
- Hormone receptor status not specified
PATIENT CHARACTERISTICS:
- Understands English
- Menopausal status not specified
PRIOR CONCURRENT THERAPY:
- See Diseases Characteristics
We found this trial at
5
sites
Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center We all know...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials